Top compounds associated with response to SPRY4


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 1e-11
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 1e-11
mRNA PD318088 CTRPv2 pan-cancer AAC 0.27 3e-13
mRNA AZD6244 CCLE pan-cancer AAC 0.28 4e-08
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.3 4e-14
mRNA PD-0325901 CCLE pan-cancer AAC 0.33 5e-12
mRNA AZD6244 FIMM pan-cancer AAC 0.35 0.08
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.35 3e-12
mRNA PLX4720 CTRPv2 pan-cancer AAC 0.35 2e-21
mRNA paclitaxel UHNBreast pan-cancer AAC 0.36 0.3
Download CSV